Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

CW

Curtiss-Wright boosts share repurchase program to $700 million

Curtiss-Wright expanded its share repurchase authorization by $510 million, lifting the total available program to $700 million from $190 million previously. The company said it will immediately repurchase an additional $100 million of stock through a 10b5-1 program.

The company also declared a quarterly dividend of $0.26 per share, payable Oct. 9, 2026, to stockholders of record on Sept. 25, 2026.

The latest move follows a series of buyback increases in August, when Curtiss-Wright added two separate $100 million expansions to its 2026 repurchase program and another $100 million in conditional repurchases. It is also continuing a $60 million repurchase program launched in January 2026 to offset potential dilution from compensation plans, which it expects to finish this year.

Curtiss-Wright said that once these programs are completed, annual share repurchases are expected to total $460 million in 2026, slightly below last year’s record $466 million buyback. Since 2021, the company said it has returned more than $1.5 billion to shareholders through share repurchases.

After the newly announced authorization, Curtiss-Wright said it will enter 2027 with $600 million of remaining open repurchase capacity. Today the company's shares have moved -1.32% to a price of $551.535. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS